Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bachem Holding AG (BANB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9769
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and biotechnology industries. Bachem’s research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. It also provides active pharmaceutical ingredients and custom synthesis. These products and services include peptides indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others; research ingredients; new chemical entities; and generics. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG (BANB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bachem Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Acquisition 15
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG – Key Competitors 16
Bachem Holding AG – Key Employees 17
Bachem Holding AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 20, 2018: Bachem: Footprint in Asia 19
Financial Announcements 20
Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit 20
Corporate Communications 21
Oct 26, 2018: Thomas Meier to become new COO of Bachem Group 21
Other Significant Developments 22
Mar 16, 2018: Bachem: Fiscal year 2017 – Continued increase in sales, profitability and earnings 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bachem Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG, Key Competitors 16
Bachem Holding AG, Key Employees 17
Bachem Holding AG, Subsidiaries 18

List of Figures
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Achira Labs Pvt Ltd:企業の製品パイプライン分析2018
    Summary Achira Labs Pvt Ltd (Achira Labs) is an immunodiagnostics company that develops diagnostics solutions for developing countries. The company offers ACIX100, a microfluidics platform that combines a plastic disposable cartridge containing dry reagents and a desktop reader instrument. Its ACIX …
  • MAEC-Kazatomprom LLP:企業の戦略的SWOT分析
    MAEC-Kazatomprom LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Citizens Financial Corp.:企業の戦略・SWOT・財務情報
    Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report Summary Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Uelzena eG:企業の戦略・SWOT・財務分析
    Uelzena eG - Strategy, SWOT and Corporate Finance Report Summary Uelzena eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • FMT Aircraft Gate Support Systems AB:企業の戦略・SWOT・財務情報
    FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report Summary FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • IMEXHS Ltd (IME):企業の財務・戦略的SWOT分析
    IMEXHS Ltd (IME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cafe De Coral Holdings Limited:企業の戦略・SWOT・財務分析
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Windtree Therapeutics Inc:企業の戦略・SWOT・財務分析
    Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alma Media Corporation:企業のM&A・事業提携・投資動向
    Alma Media Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alma Media Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • The Timken Co (TKR):企業の財務・戦略的SWOT分析
    The Timken Co (TKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Southern Co:発電所・企業SWOT分析
    Southern Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Gerdau S.A.:企業の戦略・SWOT・財務情報
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • BorgWarner Inc.:企業の戦略・SWOT・財務情報
    BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report Summary BorgWarner Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SAS Institute Inc.:戦略・SWOT・企業財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Walt Disney Company:戦略・SWOT・企業財務分析
    The Walt Disney Company - Strategy, SWOT and Corporate Finance Report Summary The Walt Disney Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gothaer Asigurari Reasigurari S.A.:企業の戦略・SWOT・財務情報
    Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report Summary Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆